Simplex Trading
KYMR icon

Simplex Trading’s Kymera Therapeutics KYMR Stock Holding History

Simplex Trading’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20
Closed -$729 – 9106
2024
Q4 		$0 Buy
+20
New +$903 ﹤0.01% 9112
2022
Q4 		– Sell
-3,922
Closed -$105K – 9832
2022
Q3 		$85K Buy
3,922
+3,646
+1,321% +$96.1K ﹤0.01% 5743
2022
Q2 		$5K Sell
276
-3,449
-93% -$80.6K ﹤0.01% 8833
2022
Q1 		$157K Buy
3,725
+3,720
+74,400% +$157K ﹤0.01% 5505
2021
Q4 		$0 Sell
5
-1,355
-100% -$78.9K ﹤0.01% 10958
2021
Q3 		$76K Buy
1,360
+1,018
+298% +$59K ﹤0.01% 6995
2021
Q2 		$16K Buy
+342
New +$14.8K ﹤0.01% 8768

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Simplex Trading's KYMR Position: Q1 2025 in Review

Simplex Trading sold out of Kymera Therapeutics (KYMR) in Q1 2025, closing a stake of 20 shares — an estimated $729 sold.

Simplex Trading first reported a position in KYMR in Q2 2021 and held it in 7 quarters. The position peaked at $157K in Q1 2022. 173 funds tracked by Wall St. Rank hold KYMR as of Q1 2025.

  • Simplex Trading reported no remaining Kymera Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 20 Kymera Therapeutics shares in Q1 2025, an estimated $729.
  • Simplex Trading first reported a position in Kymera Therapeutics in Q2 2021 and held it in 7 quarters.
  • Simplex Trading's Kymera Therapeutics position peaked at $157K in Q1 2022.
  • 173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.